Finance

Beta
Lists
ERMA:STO
Enorama Pharma AB
SEK 0.34
-11.26%
(-0.043) 1D
Jun 4, 5:00:00 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ERMA...
Open
SEK 0.36
High
SEK 0.38
Low
SEK 0.34
Mkt. cap
25.42M
Avg. vol.
43.53K
Volume
3.44K
52-wk high
SEK 3.58
52-wk low
SEK 0.21
EPS
-SEK 0.91
Shares outstanding
74.59M
No. of employees
4
Open
SEK 0.36
High
SEK 0.38
Low
SEK 0.34
Mkt. cap
25.42M
Avg. vol.
43.53K
Volume
3.44K
52-wk high
SEK 3.58
52-wk low
SEK 0.21
EPS
-SEK 0.91
Shares outstanding
74.59M
No. of employees
4
News stories
From sources across the web
About Enorama Pharma AB
CEOMats Rönngard
Employees4
Founded2006
Headquarters-
SectorPharmaceutical industry
Websiteenorama.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
734.00K
-193.00K
1.75M
1.57M
Cost of goods sold
3.19M
1.07M
5.28M
-58.00K
Cost of revenue
3.19M
1.07M
5.28M
-58.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.32M
10.91M
14.68M
11.99M
Operating expense
12.86M
11.07M
14.24M
12.51M
Total operating expenses
16.06M
12.15M
19.52M
12.45M
Operating income
-15.32M
-12.34M
-17.77M
-10.88M
Other non operating income
2.00K
-
-8.00K
-1.00K
EBT including unusual items
-18.71M
-13.35M
-20.57M
-12.64M
EBT excluding unusual items
-18.71M
-13.35M
-20.57M
-12.64M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
405.00K
78.00K
-539.00K
424.00K
Net income
-18.71M
-13.35M
-20.57M
-12.64M
Net profit margin
-2,548.77%
6,915.03%
-1,175.66%
-803.88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
9.08M
1.51M
Interest expense
-3.39M
-1.01M
-
-3.28M
Net interest expenses
-3.39M
-1.01M
9.08M
-1.77M
Depreciation and amortization charges
145.00K
89.00K
92.00K
90.00K
EBITDA
-15.18M
-12.34M
-17.68M
-10.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer